Patents by Inventor Brandon James Walsh

Brandon James Walsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
    Publication number: 20250127773
    Abstract: The present invention relates to methods of treating heart failure by administering certain compounds that modulate the activity of the beta-3 adrenergic receptor.
    Type: Application
    Filed: August 5, 2022
    Publication date: April 24, 2025
    Applicant: Arena Pharmaceuticals, Inc.
    Inventor: Brandon James Walsh
  • METHODS OF TREATMENT
    Publication number: 20240252503
    Abstract: Provided are methods of treating or preventing Raynaud's, comprising prescribing and/or administering to an individual in need thereof 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide (Compound 1), or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
    Type: Application
    Filed: May 27, 2022
    Publication date: August 1, 2024
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Brandon James Walsh, John William Adams
  • Methods of Treatment
    Publication number: 20240058350
    Abstract: Provided are methods for the parenteral use of 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and the sequential use of parenteral and oral formulations of 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide, or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
    Type: Application
    Filed: December 30, 2021
    Publication date: February 22, 2024
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: John William Adams, Prodromos Anthopoulos, Kathe Lynn Stauber, Brandon James Walsh